Abiopharma

🔍 Climer Crystal (Executive)

Company: Premier, Inc. (PINC)

Report Date: 2025-08-22

Detailed Transactions and Holdings:

• Acquired 1,082 shares of Class A Common Stock at $25.14 per share (Direct)
  Date: 2025-08-22 | Code: A | equity_swap_involved: false | shares_owned_after: 54,185.00 | transaction_form_type: 4
• Sold 311 shares of Class A Common Stock at $25.14 per share (Direct)
  Date: 2025-08-22 | Code: F | equity_swap_involved: false | shares_owned_after: 53,874.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 350 shares of Class A Common Stock at $25.14 per share (Direct)
  Date: 2025-08-22 | Code: F | equity_swap_involved: false | shares_owned_after: 53,524.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,488 shares of Class A Common Stock at $25.14 per share (Direct)
  Date: 2025-08-23 | Code: F | equity_swap_involved: false | shares_owned_after: 52,036.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 425 shares of Class A Common Stock at $25.7 per share (Direct)
  Date: 2025-08-25 | Code: F | equity_swap_involved: false | shares_owned_after: 51,611.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Reflects the number of shares of the issuer's Common Stock that were withheld to cover tax liability in connection with vesting and settlement of stock unit grants reported on this Form 4.
• F2: Reflects the number of shares of the issuer's Common Stock that were withheld to cover tax liability in connection with vesting and settlement of stock unit grants reported on a prior Form 4.